# A Prospective, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of LasoperinTM on Cognitive Function in Healthy Adults

> **NCT05994391** · NA · COMPLETED · sponsor: **Lindenwood University** · enrollment: 100 (actual)

## Conditions studied

- Cognitive Impairment
- Cognitive Decline
- Cognition Disorders in Old Age
- Well-Being, Psychological
- Inflammation
- Cognitive Fun

## Interventions

- **DIETARY_SUPPLEMENT:** LasoperinTM
- **DIETARY_SUPPLEMENT:** Placeo

## Key facts

- **NCT ID:** NCT05994391
- **Lead sponsor:** Lindenwood University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-03
- **Primary completion:** 2022-10-18
- **Final completion:** 2022-10-18
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2023-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05994391

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05994391, "A Prospective, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of LasoperinTM on Cognitive Function in Healthy Adults". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT05994391. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*